Project Grant R01DK148707
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the Trustees of Indiana University $180,900 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant K23DK149459) to conduct mentored patient-oriented research on biomarker-guided early risk stratification for fluid imbalance and acute kidney injury in neonates. The research addresses neonatal fluid overload and acute kidney injury, complications...
- The National Institute of Diabetes and Digestive and Kidney Diseases, a component of the Department of Health and Human Services National Institutes of Health, awarded $674,691 to the Trustees of Indiana University (doing business as Indiana University Indianapolis) on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research investigating alternative splicing of uromodulin (AS-UMOD) as a protective mechanism against...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $847,498 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and validate strategies for integrating deceased-donor-initiated kidney paired donation (DD-KPD) chains into the U.S. kidney allocation system. The project addresses the kidney shortage and stagnation in living donation by redirecting a small percentage of deceased...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $237,750 Project Grant to the Trustees of Indiana University (Indiana University Indianapolis) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period September 15, 2025 through August 31, 2027. The award supports a rigorous qualitative research study examining nephrology practices' participation decisions and care model reforms...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $872,273 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify modifiable process delays in deceased donor kidney allocation through process mining analysis. The project applies process mining methodology to discover actual kidney placement workflows from data logs at multiple organ procurement organizations (OPOs). The research...
- Federal Grant Award Summary Indiana University Indianapolis received a $234,287 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 15, 2025, with completion targeted for August 31, 2027. This award funds research to investigate the social and environmental determinants of vitamin D deficiency in pediatric chronic kidney disease (CKD)...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University (doing business as New York University School of Medicine) $1.674 million on September 24, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop an empirically-based, optimal prehabilitation program for kidney transplant candidates on hemodialysis. The research addresses a significant clinical need: of more than 140,000 people waiting for kidney...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $847,495 on February 19, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to build expert consensus on stratified kidney allocation design, estimate the policy impact of stratified allocation systems to assist policymakers, and investigate patient, care partner, and provider attitudes and perceptions regarding shared decision-making...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Indiana University Indianapolis (Trustees of Indiana University) $104,433 on January 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the interaction between parathyroid hormone and muscle-derived irisin in chronic kidney disease–mineral bone disorder. The research examines mechanisms by which elevated parathyroid hormone in kidney disease patients...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Ann & Robert H Lurie Children's Hospital of Chicago $164,580 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant K08DK147611) to investigate immune-mediated mechanisms of tubulointerstitial injury in childhood nephrotic syndrome. The award funds basic research characterizing how dendritic cells and related inflammatory pathways contribute...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded Indiana University Indianapolis $1,391,076 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate barriers to timely pediatric kidney transplantation listing. The project, titled "Dissecting Missed Pediatric Priority in Kidney Transplant," examines why approximately 24 percent of children on dialysis fail to obtain priority listing before age 18, despite the pediatric kidney transplant allocation system's priority protection for those listed before that deadline. Preliminary data indicate that adolescents who miss priority listing face a threefold longer transplant wait time, prolonging dialysis exposure and increasing risk of irreversible complications including premature cardiovascular calcification, neurocognitive delays, and early mortality. The research aims to identify and address the systemic, clinical, and logistical factors underlying this "missed priority" gap in order to improve transplant access and patient outcomes in the approximately 5,500 U.S. children living with end-stage kidney disease. Work is performed in Indianapolis, Indiana. The period of performance runs through April 30, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/31/26 | ||
| Not listed | $695.5k | 8/5/26 |